Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implications
- DOI
- 10.1186/s12885-025-15537-3
- Published
- 2026-02-04
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-025-15537-3,
title = {Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implications},
author = {Emad Shash and Mehemet Ali Vardar and Cagatay Taskiran and Salha Boujassoum and Jamila Riromar and Ahmed Aboutaleb and Farah Sadek and Eman Samy and Waleed Bahaj},
year = {2026},
journal = {BMC Cancer},
doi = {10.1186/s12885-025-15537-3},
url = {https://doi.org/10.1186/s12885-025-15537-3}
}RIS
TY - JOUR TI - Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implications AU - Emad Shash AU - Mehemet Ali Vardar AU - Cagatay Taskiran AU - Salha Boujassoum AU - Jamila Riromar AU - Ahmed Aboutaleb AU - Farah Sadek AU - Eman Samy AU - Waleed Bahaj PY - 2026 JO - BMC Cancer DO - 10.1186/s12885-025-15537-3 UR - https://doi.org/10.1186/s12885-025-15537-3 ER -
APA
Shash, E., Vardar, M. A., Taskiran, C., Boujassoum, S., Riromar, J., Aboutaleb, A., Sadek, F., Samy, E., & Bahaj, W. (2026). Homologous recombination deficiency in newly diagnosed advanced ovarian cancer across nine Middle East countries: prevalence, real-world testing pathways, and treatment implications. BMC Cancer. https://doi.org/10.1186/s12885-025-15537-3
Source records
- crossref · retrieved 2026-09-26T02:29:58.392Z